Levacetylleucine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for levacetylleucine and what is the scope of patent protection?
Levacetylleucine
is the generic ingredient in one branded drug marketed by Intrabio and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for levacetylleucine
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in levacetylleucine? | levacetylleucine excipients list |
| DailyMed Link: | levacetylleucine at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for levacetylleucine
Generic Entry Date for levacetylleucine*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
FOR SUSPENSION;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for levacetylleucine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intrabio | AQNEURSA | levacetylleucine | FOR SUSPENSION;ORAL | 219132-001 | Sep 24, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
